Cover Image

Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation

AbstractDoublecortin-like kinase 1 (DCLK) is a microtubule-associated serine/threonine kinase that is upregulated in a wide range of cancers and is believed to be related to tumour growth and development. Upregulated DCLK1 has been used to identify patients at high risk of cancer progression and tum...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pengming Pan (Author), Dengbo Ji (Author), Zhongjun Li (Author), Xiangbao Meng (Author)
Format:	Book
Published:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma
by: Emily M. Christman, et al.
Published: (2019)

Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors
by: Mohammed M. Alanazi, et al.
Published: (2023)

Spatiotemporal pattern of doublecortin expression in the retina of the sea lamprey
by: Blanca eFernández-López, et al.
Published: (2016)

Widespread Doublecortin Expression in the Cerebral Cortex of the Octodon degus
by: Thomas van Groen, et al.
Published: (2021)

Doublecortin-Expressing Neurons in Chinese Tree Shrew Forebrain Exhibit Mixed Rodent and Primate-Like Topographic Characteristics
by: Jia-Qi Ai, et al.
Published: (2021)

Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors
by: Tiantian Fan, et al.
Published: (2023)

Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni.
by: Thavy Long, et al.
Published: (2016)

Design, synthesis and evaluation of a series of potential prodrugs of a Bruton's tyrosine kinase (BTK) inhibitor
by: Zhou-Peng Xiao, et al.
Published: (2023)

Design, synthesis and cytotoxic evaluation of novel bis-thiazole derivatives as preferential Pim1 kinase inhibitors with in vivo and in silico study
by: Mohammad M. Al-Sanea, et al.
Published: (2023)

Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
by: Ashwag S. Alanazi, et al.
Published: (2023)

Synthesis and bioactivities evaluation of oleanolic acid oxime ester derivatives as α-glucosidase and α-amylase inhibitors
by: Xu-Yang Deng, et al.
Published: (2022)

Doublecortin-expressing cells persist in the associative cerebral cortex and amygdala in aged nonhuman primates
by: Xue-mei Zhang, et al.
Published: (2009)

Design, synthesis and biological evaluation of erlotinib-based IDO1 inhibitors
by: Xi-xi Hou, et al.
Published: (2022)

Kojic acid-derived tyrosinase inhibitors: synthesis and bioactivity
by: Seyedeh Mahdieh Hashemi, et al.
Published: (2015)

Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors
by: Igor A. Schepetkin, et al.
Published: (2022)

Design, Synthesis, and Biological Evaluation of PKD Inhibitors
by: Marie-Céline Frantz, et al.
Published: (2011)

Rational design and synthesis of 2-(1H-indazol-6-yl)-1H-benzo[d]imidazole derivatives as inhibitors targeting FMS-like tyrosine kinase 3 (FLT3) and its mutants
by: Daseul Im, et al.
Published: (2022)

Recent Progress in Development of Polo-Like Kinase 1 Inhibitors: Efforts So Far
by: Ramesh L. Sawant, et al.
Published: (2021)

Synthesis and Evaluation of 5-(Heteroarylmethylene)hydantoins as Glycogen Synthase Kinase-3β Inhibitors
by: Nicholas O. Schneider, et al.
Published: (2024)

Design, Synthesis, and Evaluation of Benzoheterocyclic-Containing Derivatives as Novel HDAC1 Inhibitors
by: Min-Ru Jiao, et al.
Published: (2022)

Design, synthesis, and biological evaluation of thiazole/thiadiazole carboxamide scaffold-based derivatives as potential c-Met kinase inhibitors for cancer treatment
by: Xiang Nan, et al.
Published: (2023)

Design and Synthesis of Novel Nordihydroguaiaretic Acid (NDGA) Analogues as Potential FGFR1 Kinase Inhibitors With Anti-Gastric Activity and Chemosensitizing Effect
by: Qian Chen, et al.
Published: (2020)

Synthesis and Bioactivity of Thiazolethioacetamides as Potential Metallo-β-Lactamase Inhibitors
by: Yi-Lin Zhang, et al.
Published: (2020)

Design, synthesis, and evaluation of curcumin analogues as potential inhibitors of bacterial sialidase
by: Bo Ram Kim, et al.
Published: (2018)

Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine-hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer
by: Mona M. Abdel-Atty, et al.
Published: (2021)

Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors
by: Audat SA, et al.
Published: (2022)

Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors
by: Lingyue Zhao, et al.
Published: (2022)

Computational Design of Novel Tau-Tubulin Kinase 1 Inhibitors for Neurodegenerative Diseases
by: Shahzaib Ahamad, et al.
Published: (2024)

Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors
by: Shanbo Yang, et al.
Published: (2022)

Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties
by: Ennian Li, et al.
Published: (2022)

Design and synthesis of benzodiazepines as brain penetrating PARP-1 inhibitors
by: Jiang Yu, et al.
Published: (2022)

Neonatal sclerosing cholangitis with novel mutations in DCDC2 (doublecortin domain-containing protein 2) in Chinese children
by: Xia Wei, et al.
Published: (2023)

Prenatal genesis of layer II doublecortin expressing neurons in neonatal and young adult guinea pig cerebral cortex
by: Yan eYang, et al.
Published: (2015)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
by: Magda A.-, et al.
Published: (2018)

Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
by: Somayyeh Ghareghomi, et al.
Published: (2023)

Synthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1
by: Patrycja Wińska, et al.
Published: (2023)

Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2
by: Faten Alchab, et al.
Published: (2015)

Design and synthesis of a novel photoaffinity probe for labelling EGF receptor tyrosine kinases
by: You-Guang Zheng, et al.
Published: (2017)

In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Mycobacterium tuberculosis
by: Venugopala KN, et al.
Published: (2020)

Lichen planopilaris-like eruption during treatment with tyrosine kinase inhibitor nilotinib
by: Juliana Ribeiro Leitão, et al.
Published: (2016)